Premini Mahendra

3.5k total citations
33 papers, 1.9k citations indexed

About

Premini Mahendra is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Premini Mahendra has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Premini Mahendra's work include Hematopoietic Stem Cell Transplantation (8 papers), Immune Cell Function and Interaction (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Premini Mahendra is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Immune Cell Function and Interaction (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Premini Mahendra collaborates with scholars based in United Kingdom, United States and Germany. Premini Mahendra's co-authors include Charles Craddock, Paul Moss, Ronjon Chakraverty, Donald Milligan, Sudhir Tauro, Husam Osman, G Hale, Stephen Mackinnon, Chris Fegan and Karl S. Peggs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Premini Mahendra

33 papers receiving 1.9k citations

Peers

Countries citing papers authored by Premini Mahendra

Since Specialization

Citations

This map shows the geographic impact of Premini Mahendra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Premini Mahendra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Premini Mahendra more than expected).

Fields of papers citing papers by Premini Mahendra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Premini Mahendra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Premini Mahendra. The network helps show where Premini Mahendra may publish in the future.

Co-authorship network of co-authors of Premini Mahendra

This figure shows the co-authorship network connecting the top 25 collaborators of Premini Mahendra. A scholar is included among the top collaborators of Premini Mahendra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Premini Mahendra. Premini Mahendra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant 2013 ·Leukemia Research ·Emmanouil Nikolousis, Stephen Robinson, Sandeep Nagra, Cassandra Brookes, Francesca Kinsella, Sudhir Tauro, Sally Jeffries, Mike Griffiths, Premini Mahendra, Mark Cook, Shankara Paneesha, Richard Lovell, Bhuvan Kishore, Sridhar Chaganti, Ram Malladi, Manoj Raghavan, Paul Moss, D Milligan, Charles Craddock	23
2	Dose‐intensified treatment of Burkitt lymphoma and B‐cell lymphoma unclassifiable, (with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols 2010 ·American Journal of Hematology ·Sudhir Tauro, Lynda Cochrane, Grete F. Lauritzsen, Lee D. Baker, Jan Delabie, Claudia Roberts, Premini Mahendra, Harald Holte	9
3	The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study 2006 ·British Journal of Haematology ·Jennifer M. Bird, (unknown), Bhawna Sirohi, Jane F. Apperley, Ann Hunter, John A. Snowden, Premini Mahendra, Donald Milligan, Jenny Byrne, Timothy J. Littlewood, Chris Fegan, Grant McQuaker, Antonio Pagliuca, Peter Johnson, Amin Rahemtulla, Curly Morris, David I. Marks	44
4	Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia 2005 ·Journal of Clinical Oncology ·Sudhir Tauro, Charles Craddock, Karl S. Peggs, Gulnaz Begum, Premini Mahendra, Gordon Cook, Judith Marsh, Donald Milligan, Anthony P. Goldstone, Ann Hunter, Asim Khwaja, Raj Chopra, Timothy J. Littlewood, Andrew Peniket, Anne Parker, Graham Jackson, G Hale, Mark Cook, Nigel H. Russell, Stephen Mackinnon	174
5	Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. 2003 ·UCL Discovery (University College London) ·K Peggs, (unknown), (unknown), Premini Mahendra, D W Milligan, (unknown), Ann Hunter, Ruth Pettengell, (unknown), G Hale, Herman Waldmann, Emma Morris, AH Goldstone, DC Linch, Stephen Mackinnon	5
6	Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1 2003 ·Transplantation ·Fiona Clark, Lisa M. Freeman, Andrzej Dzionek, Jürgen Schmitz, Dominic McMullan, Peter Simpson, Joanne Mason, Premini Mahendra, Charles Craddock, Mike Griffiths, Paul Moss, Ronjon Chakraverty	46
7	The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia 2003 ·Blood ·Mark Cook, Donald Milligan, Chris Fegan, Philip Darbyshire, Premini Mahendra, Charles Craddock, Paul Moss, David Briggs	151
8	Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure 2002 ·Bone Marrow Transplantation ·Sudhir Tauro, (unknown), Neill Duncan, Graham Lipkin, Nicholas T. Richards, Premini Mahendra	19
9	Chloroma (aleukaemic leukaemia cutis) initially diagnosed as cutaneous lymphoma 2002 ·Clinical and Experimental Dermatology ·Samantha Beswick, Edward L. Jones, Premini Mahendra, J.R. Marsden	9
10	Burkitt's lymphoma: single-centre experience with modified BFM protocol 2002 ·Clinical & Laboratory Haematology ·E. A. Harris, Shankaranarayana Paneesha, Nicholas Jackson, Laura Jones, Premini Mahendra	6
11	Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. 2001 ·UCL Discovery (University College London) ·PD Kottaridis, DW Milligan, (unknown), Charles Craddock, (unknown), K Peggs, (unknown), Johanne Geary, (unknown), Premini Mahendra, (unknown), A M Hunter, Ruth Pettengell, G Hale, Herman Waldmann, DC Linch, AH Goldstone, Stephen Mackinnon	4
12	Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy 2001 ·Bone Marrow Transplantation ·E. A. Harris, Premini Mahendra, (unknown), (unknown), R Chatterjee	10
13	Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions 2001 ·Bone Marrow Transplantation ·Sudhir Tauro, Premini Mahendra	9
14	Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma 2000 ·Bone Marrow Transplantation ·Sudhir Tauro, (unknown), Gary Richardson, M. Hastings, Premini Mahendra	8
15	A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. 1999 ·Blood ·PD Kottaridis, (unknown), D W Milligan, Sakti Chakrabarti, Stephen Robinson, (unknown), Ruth Pettengell, Judith Marsh, Premini Mahendra, Stephen Schey, (unknown), Casey Williams, G Hale, Herman Waldmann, D C Linch, Stephen Devereux, A. H. Goldstone, Stephen Mackinnon	6
16	Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin. 1996 ·PubMed ·(unknown), (unknown), Premini Mahendra, (unknown), (unknown), (unknown)	29
17	TGFβ₁and IL-4 Have Opposing Effects on the Proliferation of Chronic Phase Chronic Myeloid Leukaemic Cells Stimulated by G-CSF In Vitro 1994 ·Leukemia & lymphoma ·Premini Mahendra, Rita Barfoot, J. B. G. Bell, J Treleaven, R Powles, Jeremy Millar, B. C. Millar	2
18	Two Unusual Neurological Presentations of Granulocytic Sarcoma in Philadelphia Positive Chronic Myeloid Leukaemia 1994 ·Leukemia & lymphoma ·Premini Mahendra, (unknown), (unknown), (unknown), Anthony R. Green, R. E. Marcus	14
19	An Unusual Presentation of Acute Mveloid Leukaernia with Pericardial and Pleural Effusions Due to Granulocytic Sarcoma 1993 ·Leukemia & lymphoma ·(unknown), Raymond Powles, J Norton, Premini Mahendra, Paul Mitchell, (unknown), Jayesh Mehta, Jennie Treleaven	17
20	Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: A pilot study 1990 ·Leukemia Research ·Donald Macdonald, (unknown), (unknown), Premini Mahendra, R. Oskam, Peter Palmer, C.R. Franks, A. John Barrett	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact